The US domestic capacity to manufacture medical countermeasures would be more readily available in future public health emergencies under bipartisan legislation the Senate Health, Education, Labor and Pensions Committee has drafted to begin a discussion in Congress on lessons learned from the response to the COVID-19 pandemic.
The legislative debate is getting under way just as the Health and Human Services Department’s Biomedical Advanced Research and Development...